Can a patient develop varicella rash after receiving the chickenpox and shingles vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Patients Develop Varicella Rash After Chickenpox and Shingles Vaccines?

Yes, patients can develop a varicella-like rash after receiving varicella (chickenpox) vaccine, though this occurs infrequently and is typically mild. The vaccine-strain rash appears in approximately 3-5% of vaccinees, occurring at a median of 21 days post-vaccination (range 5-42 days), with a median of 5 lesions 1.

Distinguishing Vaccine-Strain vs. Wild-Type Rash

When evaluating post-vaccination rash, timing is critical for determining the cause:

  • Wild-type varicella rash: Occurs at a median of 8 days post-vaccination (range 1-24 days) and represents actual chickenpox infection acquired around the time of vaccination 1
  • Vaccine-strain rash: Occurs later at a median of 21 days post-vaccination (range 5-42 days) and is caused by the attenuated vaccine virus 1

PCR analysis confirmed that the majority of rash events occurring within 42 days of vaccination during the first 4 years of the vaccination program were caused by wild-type virus, not vaccine strain 1.

Characteristics of Vaccine-Associated Rash

The vaccine-related rash has distinct features:

  • Lesion count: Typically presents with approximately 5 lesions (median), though can range from 0-23 lesions 1
  • Timing: Two peaks of occurrence—7-21 days and 0-23 days post-vaccination 1
  • Severity: Generally mild and self-limited 1
  • Location: May occur at injection site (2.3% with MMRV vaccine) or generalized 1, 2

Transmission Risk from Vaccinated Individuals

Transmission of vaccine virus from vaccinated persons to susceptible contacts is extremely rare but possible 1:

  • Only 8 documented cases of vaccine virus transmission have been reported since program implementation, all from persons who developed a rash after vaccination 1
  • No transmission has been documented from vaccinated healthcare personnel 1
  • Risk is increased only in vaccinees who develop a varicella-like rash after vaccination, though even this risk remains low 1

Management of Healthcare Personnel with Post-Vaccination Rash

Healthcare workers who develop a vaccine-related rash should follow specific precautions 1:

  • Avoid contact with persons without evidence of immunity who are at risk for severe disease and complications
  • Duration of precautions: Until all lesions resolve (are crusted over), or if lesions don't crust (macules and papules only), until no new lesions appear within a 24-hour period 1
  • Recently vaccinated healthcare personnel without rash require no work restrictions 1

Herpes Zoster (Shingles) After Vaccination

Herpes zoster can occur after varicella vaccination, but at substantially lower rates than after natural infection 1:

  • Post-vaccination rate: 2.6 per 100,000 vaccine doses distributed 1
  • Post-natural infection rate: 68 per 100,000 person-years in children <20 years, and 215 per 100,000 person-years for all ages 1
  • Onset range for PCR-confirmed herpes zoster after vaccination: 25-722 days 1

Studies in leukemic children (a sentinel population) suggest vaccination may actually reduce the risk of zoster compared to natural infection 3.

Serious Adverse Events

Severe complications from vaccine-strain virus are rare and include 1:

  • Pneumonia
  • Hepatitis
  • Severe disseminated varicella infection
  • Secondary transmission (5 documented cases)

Critical caveat: These severe cases occurred almost exclusively in immunocompromised patients or persons with undiagnosed serious medical conditions at the time of vaccination 1.

Clinical Implications for Two-Dose Vaccination

The incidence of varicella-like rashes is lower after a second dose of MMRV (0.0%) compared to concomitant administration of separate MMR and varicella vaccines as second doses (1.9%) 1. The CDC now recommends two doses administered 4-8 weeks apart for optimal protection 4.

Common Pitfalls to Avoid

  • Do not assume all post-vaccination rashes are vaccine-related: Most rashes occurring within 2 weeks are wild-type virus 1
  • Do not unnecessarily restrict vaccinated healthcare workers: Only those with visible rash require precautions 1
  • Do not confuse mild localized reactions with true varicella: Injection site reactions (erythema, swelling) are common and do not represent varicella 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Urticarioid Reaction after MPRV Vaccine in a 6-Year-Old Child

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prospects for use of a varicella vaccine in adults.

Infectious disease clinics of North America, 1990

Guideline

Risk of Contracting Chickenpox Despite Vaccination

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.